This accumulation of hepatic DAG species in HFHS group could lead to insulin resistance and the development of hepatic steatosis [2] via protein kinase C ε (PKCε) activation and the resulting inhibition of the insulin receptor, as previously described [5,38]. The gene discussed is PRKCE; the disease is fatty liver disease.